BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29623391)

  • 1. Association between memory B-cells and clinical and immunological features of primary Sjögren's syndrome and Sicca patients.
    Barcelos F; Martins C; Papoila A; Geraldes C; Cardigos J; Nunes G; Lopes T; Alves N; Vaz-Patto J; Branco J; Borrego LM
    Rheumatol Int; 2018 Jun; 38(6):1063-1073. PubMed ID: 29623391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of lymphocyte phenotype profile to differentiate primary Sjögren's syndrome from sicca syndrome.
    Loureiro-Amigo J; Palacio-García C; Martínez-Gallo M; Martínez-Valle F; Ramentol-Sintas M; Soláns-Laqué R
    Rheumatology (Oxford); 2021 Dec; 60(12):5647-5658. PubMed ID: 33620072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjögren's syndrome.
    Loureiro-Amigo J; Franco-Jarava C; Perurena-Prieto J; Palacio C; Martínez-Valle F; Soláns-Laqué R
    Clin Exp Rheumatol; 2021; 39 Suppl 133(6):131-139. PubMed ID: 34919042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
    Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N
    PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
    Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corneal sub-basal nerve plexus assessment and its association with phenotypic features and lymphocyte subsets in Sjögren's Syndrome.
    Barcelos F; Hipólito-Fernandes D; Martins C; Ângelo-Dias M; Cardigos J; Monteiro R; Alves N; Vaz-Patto J; da Cunha-Branco J; Borrego LM
    Acta Ophthalmol; 2021 Dec; 99(8):e1315-e1325. PubMed ID: 33683020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.
    Szabó K; Papp G; Szántó A; Tarr T; Zeher M
    Clin Exp Immunol; 2016 Jan; 183(1):76-89. PubMed ID: 26358223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FcRL4
    Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
    J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
    Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
    Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulatory effects of dental mesenchymal stem cells on T and B lymphocyte responses in primary Sjögren's syndrome.
    Genç D; Günaydın B; Sezgin S; Aladağ A; Tarhan EF
    Immunotherapy; 2022 Mar; 14(4):225-247. PubMed ID: 35012368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome.
    Bohnhorst JØ; Bjørgan MB; Thoen JE; Natvig JB; Thompson KM
    J Immunol; 2001 Oct; 167(7):3610-8. PubMed ID: 11564773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte subpopulations in Sjögren's syndrome are distinct in anti-SSA-positive patients and related to disease activity.
    Barcelos F; Martins C; Madeira N; Ângelo-Dias M; Cardigos J; Alves N; Vaz-Patto J; Cunha-Branco J; Borrego LM
    Clin Rheumatol; 2021 Jul; 40(7):2791-2804. PubMed ID: 33443605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Imbalance of Circulating Follicular T Helper Cell Subsets in Primary Sjögren's Syndrome Associates With Serological Alterations and Abnormal B-Cell Distribution.
    Szabó K; Jámbor I; Szántó A; Horváth IF; Tarr T; Nakken B; Szodoray P; Papp G
    Front Immunol; 2021; 12():639975. PubMed ID: 33815392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of diagnosis and disease course in primary Sjögren's syndrome: Results from datamining of electronic health records.
    Sandhya P; Janardana R; Sudarsanam T; Mahasampath G; Prakash JAJ; Danda D
    Int J Rheum Dis; 2019 Sep; 22(9):1768-1774. PubMed ID: 31328441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells.
    Roberts ME; Kaminski D; Jenks SA; Maguire C; Ching K; Burbelo PD; Iadarola MJ; Rosenberg A; Coca A; Anolik J; Sanz I
    Arthritis Rheumatol; 2014 Sep; 66(9):2558-69. PubMed ID: 24909310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble siglec-5 is a novel salivary biomarker for primary Sjogren's syndrome.
    Lee J; Lee J; Baek S; Koh JH; Kim JW; Kim SY; Chung SH; Choi SS; Cho ML; Kwok SK; Ju JH; Park SH
    J Autoimmun; 2019 Jun; 100():114-119. PubMed ID: 30922727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
    Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K
    Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome.
    Li L; He J; Zhu L; Yang Y; Jin Y; Jia R; Liu X; Liu Y; Sun X; Li Z
    J Immunol Res; 2015; 2015():307453. PubMed ID: 26436101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients.
    Cho HJ; Yoo JJ; Yun CY; Kang EH; Lee HJ; Hyon JY; Song YW; Lee YJ
    Rheumatology (Oxford); 2013 Dec; 52(12):2208-17. PubMed ID: 24023247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.